Morningstar has hit back at the Financial Conduct Authority's (FCA) claims its rated funds fail to outperform their benchmarks over the long term, presenting evidence to the contrary from a study conducted between 2002 and 2015.
In the FCA Asset Management Market Study, which was released last November, the regulator used the organisation as a case study, criticising the ratings agency for awarding positive ratings to funds that...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds